ArticleJournal of thrombosis and haemostasis : JTH2020

Long-term safety and efficacy of rIX-FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B.

Maria Elisa Mancuso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.